Ricardo Moreno‐Otero

Author

Also Known As

J Pajares, Mar´ia Trapero-Maruga´n, R MORENOOTERO, R Moreno-Otero, R Moreno‐Otero, R. MORENO‐OTERO, R. Moreno-Otero, R. Moreno‐Otero, Ricardo Moreno-Otero, Ricardo MorenoOtero

286

Publications

8.1K

Citations

H-Index

106

Concepts

All Affiliations

Hospital Universitario de La Princesa Universidad Autónoma de Madrid Instituto de Salud Carlos III Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Hospital Universitario de Valme

About

Ricardo Moreno‐Otero is an author at Hospital Universitario de La Princesa specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	37	3.1K
2	Health Sciences	7	7	553
3	Public Health	2	2	46
4	Allergy	2	2	358
5	Biochemistry	2	2	117

Ricardo Moreno‐Otero

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment José M. Sánchez–Tapias, M. Diago, P Escartín, Gastroenterology HepatologyHepatitis CVersus 72Viral HepatitisPeginterferon-alfa2a Plus Ribavirin	2006	360
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication Jordan J. Feld, Harald Hofer, Piero Luigi Almasio, Journal of Hepatology Cirrhosis-related ComplicationsEpidemiologyHepatologyHepatitis CViral Hepatitis	2016	273
Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity Carmelo García‐Monzón, Elena Martín‐Pérez, Oreste Lo Iacono, Journal of Hepatology ObesityMetabolic SyndromeInflammationMetabolic Associated SteatohepatitisPrognostic Factors	2000	265
Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. R González-Amaro, Carmelo García‐Monzón, Luisa Garcı́a-Buey, The Journal of Experimental Medicine Liver FibrosisImmunologyPathologyChronic Viral HepatitisCirrhosis	1994	265
Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy Thierry Poynard, Massimo Colombo, Jordi Bruix, Gastroenterology Hepatitis C WhoHepatologyHepatitis CInterferon Alfa/ribavirin TherapyViral Hepatitis	2009	234
6-Mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease José Maté-Jiménez, Carlos Hermida, José Cantero-Perona, European Journal of Gastroenterology & Hepatology	2000	224
<b>Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon‐α therapy</b> Mónica Marazuela, Luisa Garcı́a-Buey, Bárbara González‐Fernández, Clinical Endocrinology	1996	213
A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients Elena Gómez Domínguez, Javier P. Gisbert, J.A. Moreno-Monteagudo, Alimentary Pharmacology & Therapeutics	2006	188
The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection Ignacio Benedicto, Francisca Molina‐Jiménez, Birke Bartosch, Journal of Virology Molecular VirologyViral HepatitisPathogenesisImmunologyViral Pathogenesis	2009	157
Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin†‡ Manuel Romero‐Gómez, M. Diago, Raúl J. Andrade, Hepatology	2009	154

Page 1